Sanofi partners with OpenAI, Formation Bio on AI-driven drug development

Sanofi partners with OpenAI, Formation Bio on AI-driven drug development

Source: 
Reuters
snippet: 

French drugmaker Sanofi (SASY.PA) on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development projects through the use of Artificial Intelligence.